Cerebral Response to Sustained Hypoxia

大脑对持续缺氧的反应

基本信息

  • 批准号:
    7615700
  • 负责人:
  • 金额:
    $ 43.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-15 至 2012-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our overall goal is to understand the physiological consequences of global cerebral hypoxia, and how failure of the normal homeostatic mechanisms progresses to disease. To address this, it is first necessary to define the normal physiological responses to cerebral hypoxia. Cerebral hypoxia is the outcome of many disease processes (pulmonary, cardiac, cerebrovascular), and thus to investigate cerebral homeostasis mechanisms to hypoxia per se, it is important to examine them in isolation from potentially coexistent multi-system disease. In this proposal we use altitude-induced hypoxia (Acute Mountain Sickness - AMS) as a model system of isolated sustained hypoxia to study the normal physiological response mechanisms. This proposal draws hypotheses from traditional high altitude research and from functional MRI studies of cerebral physiology. We will experimentally test these existing models to explain the progression from hypoxic exposure to cerebral disease. Our specific aims are to measure the normal cerebral physiological response to acute (<6 hrs), short-term (2 days) and sustained (7 days) hypoxia (PIO2 = 90 Torr) in healthy individuals, and define the time-dependent physiologic response to hypoxia. Using MRI measurements of cerebral physiology (i.e. changes in CBF, CMRO2, CSF volume & edema) we will experimentally test individual components of the models. To systematically assess the time-course of the normal physiological responses, these measurements will be made over a range of acute and sustained hypoxic exposure. Measurements will be made in the same cohort of human subjects (encompassing AMS-susceptible andAMS-resistant individuals). These studies will provide a comprehensive picture of the cerebral physiological responses to hypoxia, and why some individuals are better able to acclimatize to low oxygen levels-we will establish a basis for understanding why patients with disease respond differently to hypoxia. Designing appropriate clinical interventions to treat chronic cerebral hypoxic decline hinges on such a comprehensive understanding.
描述(由申请人提供):我们的总体目标是了解全脑缺氧的生理后果,以及正常稳态机制的失败如何发展为疾病。为了解决这个问题,首先有必要确定脑缺氧的正常生理反应。脑缺氧是许多疾病过程(肺、心、脑血管)的结果,因此为了研究脑缺氧自身的稳态机制,重要的是将它们与潜在共存的多系统疾病分开检查。本研究以高原缺氧(Acute Mountain Sickness,AMS)为模型系统,研究高原缺氧的正常生理反应机制。该建议从传统的高海拔研究和脑生理学的功能性MRI研究中得出假设。我们将通过实验测试这些现有的模型来解释从缺氧暴露到脑疾病的进展。我们的具体目标是测量健康个体对急性(<6小时)、短期(2天)和持续(7天)缺氧(PIO 2 = 90 Torr)的正常脑生理反应,并定义对缺氧的时间依赖性生理反应。使用脑生理学的MRI测量(即CBF,CMRO2,CSF体积和水肿的变化),我们将通过实验测试模型的各个组件。为了系统地评估正常生理反应的时程,将在急性和持续低氧暴露的范围内进行这些测量。将在同一组人类受试者(包括AMS敏感和AMS耐药个体)中进行测量。这些研究将提供大脑对缺氧的生理反应的全面图景,以及为什么有些人能够更好地适应低氧水平,我们将建立一个基础,了解为什么疾病患者对缺氧的反应不同。设计适当的临床干预措施来治疗慢性脑缺氧下降取决于这样一个全面的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID DUBOWITZ其他文献

DAVID DUBOWITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID DUBOWITZ', 18)}}的其他基金

Cerebral Diffusion: A new approach to sleep disorders
脑扩散:治疗睡眠障碍的新方法
  • 批准号:
    9372571
  • 财政年份:
    2017
  • 资助金额:
    $ 43.81万
  • 项目类别:
MRI of cerebral metabolic reactivity
脑代谢反应性MRI
  • 批准号:
    9036263
  • 财政年份:
    2015
  • 资助金额:
    $ 43.81万
  • 项目类别:
Hemodynamic and Metabolic Coupling in Migraine
偏头痛的血流动力学和代谢耦合
  • 批准号:
    8624417
  • 财政年份:
    2013
  • 资助金额:
    $ 43.81万
  • 项目类别:
Hemodynamic and Metabolic Coupling in Migraine
偏头痛的血流动力学和代谢耦合
  • 批准号:
    8730250
  • 财政年份:
    2013
  • 资助金额:
    $ 43.81万
  • 项目类别:
Tissue Oxygenation and Cerebral Vulnerability to Hypoxia
组织氧合和大脑缺氧的脆弱性
  • 批准号:
    8303023
  • 财政年份:
    2012
  • 资助金额:
    $ 43.81万
  • 项目类别:
Tissue Oxygenation and Cerebral Vulnerability to Hypoxia
组织氧合和大脑缺氧的脆弱性
  • 批准号:
    8418707
  • 财政年份:
    2012
  • 资助金额:
    $ 43.81万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    7437279
  • 财政年份:
    2007
  • 资助金额:
    $ 43.81万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    8074491
  • 财政年份:
    2007
  • 资助金额:
    $ 43.81万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    7844995
  • 财政年份:
    2007
  • 资助金额:
    $ 43.81万
  • 项目类别:
Cerebral Response to Sustained Hypoxia
大脑对持续缺氧的反应
  • 批准号:
    7261041
  • 财政年份:
    2007
  • 资助金额:
    $ 43.81万
  • 项目类别:

相似海外基金

Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance
乙酰唑胺和醋甲唑胺对缺氧运动表现的影响
  • 批准号:
    572954-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 43.81万
  • 项目类别:
    University Undergraduate Student Research Awards
Acetazolamide to Improve Clinically Important Outcomes in Obstructive Sleep Apnea Patients with a High Loop Gain Endotype
乙酰唑胺可改善具有高环增益内型的阻塞性睡眠呼吸暂停患者的临床重要结果
  • 批准号:
    10524708
  • 财政年份:
    2022
  • 资助金额:
    $ 43.81万
  • 项目类别:
Development of a DNA Aptamer-Based Electrochemical Assay for Acetazolamide in Urine Using a Handheld Biosensor for Compliance Validation in Clinical Drug Trials
使用手持式生物传感器开发基于 DNA 适体的尿液中乙酰唑胺电化学检测方法,以验证临床药物试验的合规性
  • 批准号:
    9344796
  • 财政年份:
    2017
  • 资助金额:
    $ 43.81万
  • 项目类别:
Renoprotecion of acetazolamide and canagliflozin
乙酰唑胺和卡格列净的肾脏保护
  • 批准号:
    26461233
  • 财政年份:
    2014
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    6846379
  • 财政年份:
    2004
  • 资助金额:
    $ 43.81万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    7673808
  • 财政年份:
    2004
  • 资助金额:
    $ 43.81万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    7356429
  • 财政年份:
    2004
  • 资助金额:
    $ 43.81万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯那胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    7749961
  • 财政年份:
    2004
  • 资助金额:
    $ 43.81万
  • 项目类别:
Dichlorphenamide vs Acetazolamide for Periodic Paralysis
双氯苯酰胺与乙酰唑胺治疗周期性麻痹
  • 批准号:
    6723860
  • 财政年份:
    2004
  • 资助金额:
    $ 43.81万
  • 项目类别:
Sequential Changes of Cerebral Blood Flow after Acetazolamide Acetazolamide Loading in Hemodynamic Cerebral Ischemia: Relationship to Cerebral Oxygen Metabolism
血流动力学脑缺血中乙酰唑胺负荷后脑血流量的连续变化:与脑氧代谢的关系
  • 批准号:
    15591541
  • 财政年份:
    2003
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了